Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Post-Market Safety Efforts Won’t Be Impacted By Sentinel In Near Term

Executive Summary

FDA's Sentinel post-market safety monitoring project will augment, not replace, the agency's current repertoire of post-market activities and requirements for drugs, Center for Drug Evaluation and Research Director Janet Woodcock emphasized
Advertisement

Related Content

Comparative Research Needs New Approach To Answer Real-Life Questions
Comparative Research Needs New Approach To Answer Real-Life Questions
Mining The Data: WellPoint Stresses Need For Context In Safety Surveillance
FDA Track Record In Risk Communication Raised As Key Sentinel Concern
Mining The Data: WellPoint Stresses Need For Context In Safety Surveillance
FDA’s Sentinel Safety Surveillance Could Ease Phase IV Study Burden
FDA’s Sentinel Program Readies For Patrol As Stakeholders Watch For Details
FDA’s Sentinel Program Readies For Patrol As Stakeholders Watch For Details
WellPoint Drug Safety Monitoring System Expected To Go Live In Mid-2009
FDA Coffers Fill With Funds, But No Money For Reagan-Udall Or Lab Closures
Advertisement
UsernamePublicRestriction

Register

PS050467

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel